APA (7th ed.) Citation

Ana Serrano-Martínez, Desirée Victoria-Montesinos, Ana María García-Muñoz, Pilar Hernández-Sánchez, Carmen Lucas-Abellán, & Rebeca González-Louzao. (2023). A Systematic Review of Clinical Trials on the Efficacy and Safety of CRLX101 Cyclodextrin-Based Nanomedicine for Cancer Treatment. MDPI AG.

Chicago Style (17th ed.) Citation

Ana Serrano-Martínez, Desirée Victoria-Montesinos, Ana María García-Muñoz, Pilar Hernández-Sánchez, Carmen Lucas-Abellán, and Rebeca González-Louzao. A Systematic Review of Clinical Trials on the Efficacy and Safety of CRLX101 Cyclodextrin-Based Nanomedicine for Cancer Treatment. MDPI AG, 2023.

MLA (9th ed.) Citation

Ana Serrano-Martínez, et al. A Systematic Review of Clinical Trials on the Efficacy and Safety of CRLX101 Cyclodextrin-Based Nanomedicine for Cancer Treatment. MDPI AG, 2023.

Warning: These citations may not always be 100% accurate.